Research has been particularly promising for certain types of cancer:
Breast Cancer: Clinical trials are ongoing to determine the efficacy of metformin in both preventing and treating breast cancer. Colorectal Cancer: Epidemiological studies have shown a reduced incidence and improved survival rates among metformin users. Prostate Cancer: There is growing evidence that metformin may slow the progression of prostate cancer, particularly in patients with concurrent diabetes. Pancreatic Cancer: Preliminary studies suggest that metformin may improve outcomes in pancreatic cancer, although more research is needed.
